-
1
-
-
84934273067
-
-
Atlas of CKD & ESRD [online] 2012
-
US Renal Data System. 2011 Atlas of CKD & ESRD [online], http://www.usrds.org/atlas11.aspx (2012).
-
(2011)
US Renal Data System.
-
-
-
2
-
-
0034922894
-
Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: A cross-sectional study
-
Stack, A. G. & Bloembergen, W. E. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: A cross-sectional study. J. Am. Soc. Nephrol. 12, 1516-1523 (2001).
-
(2001)
J. Am. Soc. Nephrol.
, vol.12
, pp. 1516-1523
-
-
Stack, A.G.1
Bloembergen, W.E.2
-
3
-
-
0032541672
-
Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
-
Herzog, C. A., Ma, J. Z. & Collins, A. J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N. Engl. J. Med. 339, 799-805 (1998).
-
(1998)
N. Engl. J. Med.
, vol.339
, pp. 799-805
-
-
Herzog, C.A.1
Ma, J.Z.2
Collins, A.J.3
-
4
-
-
0030995276
-
Onset of coronary artery disease prior to initiation of hemodialysis in patients with end-stage renal disease
-
Joki, N., Hase, H., Nakamura, R. & Yamaguchi, T. Onset of coronary artery disease prior to initiation of hemodialysis in patients with end-stage renal disease. Nephrol. Dial. Transplant. 12, 718-723 (1997).
-
(1997)
Nephrol. Dial. Transplant.
, vol.12
, pp. 718-723
-
-
Joki, N.1
Hase, H.2
Nakamura, R.3
Yamaguchi, T.4
-
5
-
-
24344477577
-
High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination
-
Ohtake, T. et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination. J. Am. Soc. Nephrol. 16, 1141-1148 (2005).
-
(2005)
J. Am. Soc. Nephrol.
, vol.16
, pp. 1141-1148
-
-
Ohtake, T.1
-
6
-
-
33847281906
-
Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients
-
Charytan, D., Kuntz, R. E., Mauri, L. & DeFilippi, C. Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am. J. Kidney Dis. 49, 409-416 (2007).
-
(2007)
Am. J. Kidney Dis.
, vol.49
, pp. 409-416
-
-
Charytan, D.1
Kuntz, R.E.2
Mauri, L.3
DeFilippi, C.4
-
7
-
-
0036719916
-
Inflammation in end-stage renal disease: Sources, consequences, and therapy
-
Stenvinkel, P. & Alvestrand, A. Inflammation in end-stage renal disease: Sources, consequences, and therapy. Semin. Dial. 15, 329-337 (2002).
-
(2002)
Semin. Dial.
, vol.15
, pp. 329-337
-
-
Stenvinkel, P.1
Alvestrand, A.2
-
8
-
-
0027301576
-
Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup
-
Manske, C. L., Thomas, W., Wang, T. & Wilson, R. F. Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int. 44, 617-621 (1993).
-
(1993)
Kidney Int.
, vol.44
, pp. 617-621
-
-
Manske, C.L.1
Thomas, W.2
Wang, T.3
Wilson, R.F.4
-
9
-
-
0036055582
-
C reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients
-
Wanner, C. & Metzger, T. C reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol. Dial. Transplant. 17, 29-32 (2002).
-
(2002)
Nephrol. Dial. Transplant.
, vol.17
, pp. 29-32
-
-
Wanner, C.1
Metzger, T.2
-
10
-
-
0036435820
-
Cardiovascular calcification in patients with end-stage renal disease: A
-
century-old phenomenon
-
Qunibi, W. Y., Nolan, C. A. & Ayus, J. C. Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenon. Kidney Int. Suppl. 82, S73- S80 (2002).
-
(2002)
Kidney Int. Suppl.
, vol.82
-
-
Qunibi, W.Y.1
Nolan, C.A.2
Ayus, J.C.3
-
11
-
-
0031920748
-
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
-
Block, G. A., Hulbert-Shearon, T. E., Levin, N. W. & Port, F. K. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am. J. Kidney Dis. 31, 607-617 (1998).
-
(1998)
Am. J. Kidney Dis.
, vol.31
, pp. 607-617
-
-
Block, G.A.1
Hulbert-Shearon, T.E.2
Levin, N.W.3
Port, F.K.4
-
12
-
-
39049096394
-
Mechanisms of vascular calcification in chronic kidney disease
-
Moe, S. M. & Chen, N. X. Mechanisms of vascular calcification in chronic kidney disease. J. Am. Soc. Nephrol. 19, 213-216 (2008).
-
(2008)
J. Am. Soc. Nephrol.
, vol.19
, pp. 213-216
-
-
Moe, S.M.1
Chen, N.X.2
-
13
-
-
70350739118
-
Cardiovascular risk factors in patients with chronic kidney disease
-
van der Zee, S., Baber, U., Elmariah, S., Winston, J. & Fuster, V. Cardiovascular risk factors in patients with chronic kidney disease. Nat. Rev. Cardiol. 6, 580-589 (2009).
-
(2009)
Nat. Rev. Cardiol.
, vol.6
, pp. 580-589
-
-
Van Der Zee, S.1
Baber, U.2
Elmariah, S.3
Winston, J.4
Fuster, V.5
-
14
-
-
0037181496
-
Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis
-
Klassen, P. S. et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287, 1548-1555 (2002).
-
(2002)
JAMA
, vol.287
, pp. 1548-1555
-
-
Klassen, P.S.1
-
15
-
-
82455171881
-
Coronary artery disease in a large renal transplant population: Implications for management
-
Kahn, M. R., Fallahi, A., Kim, M. C., Esquitin, R. & Robbins, M. J. Coronary artery disease in a large renal transplant population: implications for management. Am. J. Transplant. 11, 2665-2674 (2011).
-
(2011)
Am. J. Transplant.
, vol.11
, pp. 2665-2674
-
-
Kahn, M.R.1
Fallahi, A.2
Kim, M.C.3
Esquitin, R.4
Robbins, M.J.5
-
16
-
-
0038645354
-
Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation
-
Patel, A. D. et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am. J. Cardiol. 92, 146-151 (2003).
-
(2003)
Am. J. Cardiol.
, vol.92
, pp. 146-151
-
-
Patel, A.D.1
-
17
-
-
0042835365
-
Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing
-
De Lima, J. J. et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 42, 263-268 (2003).
-
(2003)
Hypertension
, vol.42
, pp. 263-268
-
-
De Lima, J.J.1
-
18
-
-
84878530092
-
Cardiac testing for coronary artery disease in potential kidney transplant recipients
-
1 Art No CD008691
-
Wang, L. W. et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Systematic Reviews, Issue 1 Art. No.: CD008691 http://dx.doi.org/10.1002/14651858.CD008691.pub2 (2011).
-
(2011)
Cochrane Database Systematic Reviews
-
-
Wang, L.W.1
-
19
-
-
84864475111
-
Cardiac disease evaluation and management among kidney and liver transplantation candidates: A scientific statement from the american heart association and the american college of cardiology foundation
-
Lentine, K. L. et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 126, 617-663 (2012).
-
(2012)
Circulation
, vol.126
, pp. 617-663
-
-
Lentine, K.L.1
-
20
-
-
23844465424
-
K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients
-
K/DOQI Workgroup
-
K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am. J. Kidney Dis. 45 (Suppl. 3), S1- S153 (2005).
-
(2005)
Am. J. Kidney Dis.
, vol.45
, Issue.SUPPL. 3
-
-
-
21
-
-
79957847642
-
A call to action: Variability in guidelines for cardiac evaluation before renal transplantation
-
Friedman, S. E. et al. A call to action: variability in guidelines for cardiac evaluation before renal transplantation. Clin. J. Am. Soc. Nephrol. 6, 1185-1191 (2011).
-
(2011)
Clin. J. Am. Soc. Nephrol.
, vol.6
, pp. 1185-1191
-
-
Friedman, S.E.1
-
22
-
-
83155173970
-
2011 accf/aha guideline for coronary artery bypass graft surgery: A report of the american college of cardiology foundation/american heart association task force on practice guidelines
-
Hillis, L. D. et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124, e652- e735 (2011).
-
(2011)
Circulation
, vol.124
-
-
Hillis, L.D.1
-
23
-
-
84858330788
-
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: A systematic review and meta-analysis
-
Palmer, S. C. et al. Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: A systematic review and meta-analysis. Ann. Intern. Med. 156, 445-459 (2012).
-
(2012)
Ann. Intern. Med.
, vol.156
, pp. 445-459
-
-
Palmer, S.C.1
-
24
-
-
38749104314
-
Major bleeding in hemodialysis patients
-
Holden, R. M. et al. Major bleeding in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 3, 105-110 (2008).
-
(2008)
Clin. J. Am. Soc. Nephrol.
, vol.3
, pp. 105-110
-
-
Holden, R.M.1
-
25
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
Hansson, L. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351, 1755-1762 (1998).
-
(1998)
Lancet
, vol.351
, pp. 1755-1762
-
-
Hansson, L.1
-
26
-
-
77956525281
-
Aspirin is beneficial in hypertensive patients with chronic kidney disease: A post-hoc subgroup analysis of a randomized controlled trial
-
Jardine, M. J. et al. Aspirin is beneficial in hypertensive patients with chronic kidney disease: A post-hoc subgroup analysis of a randomized controlled trial. J. Am. Coll. Cardiol. 56, 956-965 (2010).
-
(2010)
J. Am. Coll. Cardiol.
, vol.56
, pp. 956-965
-
-
Jardine, M.J.1
-
27
-
-
79953296443
-
Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention
-
Htun, P. et al. Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention. J. Am. Soc. Nephrol. 22, 627-633 (2011).
-
(2011)
J. Am. Soc. Nephrol.
, vol.22
, pp. 627-633
-
-
Htun, P.1
-
28
-
-
78751605846
-
Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel
-
Morel, O. et al. Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. J. Am. Coll. Cardiol. 57, 399-408 (2011).
-
(2011)
J. Am. Coll. Cardiol.
, vol.57
, pp. 399-408
-
-
Morel, O.1
-
29
-
-
78149357797
-
Lack of effect of chronic kidney disease on clopidogrel response with high loading and maintenance doses of clopidogrel after acute coronary syndrome
-
Cuisset, T. et al. Lack of effect of chronic kidney disease on clopidogrel response with high loading and maintenance doses of clopidogrel after acute coronary syndrome. Thromb. Res. 126, e400- e402 (2010).
-
(2010)
Thromb. Res.
, vol.126
-
-
Cuisset, T.1
-
30
-
-
77649207350
-
Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy
-
Angiolillo, D. J. et al. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J. Am. Coll. Cardiol. 55, 1139-1146 (2010).
-
(2010)
J. Am. Coll. Cardiol.
, vol.55
, pp. 1139-1146
-
-
Angiolillo, D.J.1
-
31
-
-
0037145863
-
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
-
Clopidogrel for the Reduction of Events During Observation.
-
Steinhubl, S. R. et al. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 288, 2411-2420 (2002).
-
(2002)
JAMA
, vol.288
, pp. 2411-2420
-
-
Steinhubl, S.R.1
-
32
-
-
40849083770
-
The efficacy and safety of short-and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial
-
Best, P. J. et al. The efficacy and safety of short-and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Am. Heart J. 155, 687-693 (2008).
-
(2008)
Am. Heart J.
, vol.155
, pp. 687-693
-
-
Best, P.J.1
-
33
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
Wallentin, L. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 361, 1045-1057 (2009).
-
(2009)
N. Engl. J. Med.
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
-
34
-
-
77957270303
-
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: Results from the Platelet Inhibition and Patient Outcomes (PLATO) trial
-
James, S. et al. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: Results from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation 122, 1056-1067 (2010).
-
(2010)
Circulation
, vol.122
, pp. 1056-1067
-
-
James, S.1
-
35
-
-
36148983750
-
Prasugrel versus clopidogrel in patients with acute coronary syndromes
-
Wiviott, S. D. et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 357, 2001-2015 (2007).
-
(2007)
N. Engl. J. Med.
, vol.357
, pp. 2001-2015
-
-
Wiviott, S.D.1
-
36
-
-
68649098919
-
Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease
-
Small, D. S. et al. Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease. J. Clin. Pharm. Ther. 34, 585-594 (2009).
-
(2009)
J. Clin. Pharm. Ther.
, vol.34
, pp. 585-594
-
-
Small, D.S.1
-
37
-
-
1442316135
-
K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease
-
Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
-
Kidney Disease Outcomes Quality Initiative (K/DOQI) Group. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am. J. Kidney Dis. 41 (Suppl. 3), S1- S91 (2003).
-
(2003)
Am. J. Kidney Dis.
, vol.41
, Issue.SUPPL. 3
-
-
-
38
-
-
84865602423
-
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study
-
Tonelli, M. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study. Lancet 380, 807-814 (2012).
-
(2012)
Lancet
, vol.380
, pp. 807-814
-
-
Tonelli, M.1
-
39
-
-
0037126526
-
Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults Adult Treatment Panel III): Final report
-
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation 106, 3143-3421 (2002).
-
(2002)
Circulation
, vol.106
, pp. 3143-3421
-
-
-
40
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group.
-
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360, 7-22 (2002).
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
41
-
-
0037458229
-
Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency
-
Tonelli, M. et al. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann. Intern. Med. 138, 98-104 (2003).
-
(2003)
Ann. Intern. Med.
, vol.138
, pp. 98-104
-
-
Tonelli, M.1
-
42
-
-
20844462717
-
Effect of pravastatin on cardiovascular events in people with chronic kidney disease
-
Tonelli, M. et al. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 110, 1557-1563 (2004).
-
(2004)
Circulation
, vol.110
, pp. 1557-1563
-
-
Tonelli, M.1
-
43
-
-
41549159287
-
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: The TNT (Treating to New Targets) study
-
Shepherd, J. et al. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: The TNT (Treating to New Targets) study. J. Am. Coll. Cardiol. 51, 1448-1454 (2008).
-
(2008)
J. Am. Coll. Cardiol.
, vol.51
, pp. 1448-1454
-
-
Shepherd, J.1
-
44
-
-
22344458137
-
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
-
Wanner, C. et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353, 238-248 (2005).
-
(2005)
N. Engl. J. Med.
, vol.353
, pp. 238-248
-
-
Wanner, C.1
-
45
-
-
63849163945
-
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
-
Fellström, B. C. et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N. Engl. J. Med. 360, 1395-1407 (2009).
-
(2009)
N. Engl. J. Med.
, vol.360
, pp. 1395-1407
-
-
Fellström, B.C.1
-
46
-
-
79959746706
-
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial
-
Baigent, C. et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet 377, 2181-2192 (2011).
-
(2011)
Lancet
, vol.377
, pp. 2181-2192
-
-
Baigent, C.1
-
47
-
-
79959707564
-
SHARP: A stab in the right direction in chronic kidney disease
-
Stevens, K. K. & Jardine, A. G. SHARP: A stab in the right direction in chronic kidney disease. Lancet 377, 2153-2154 (2011).
-
(2011)
Lancet
, vol.377
, pp. 2153-2154
-
-
Stevens, K.K.1
Jardine, A.G.2
-
48
-
-
79960126385
-
Rosuvastatin in diabetic hemodialysis patients
-
Holdaas, H. et al. Rosuvastatin in diabetic hemodialysis patients. J. Am. Soc. Nephrol. 22, 1335-1341 (2011).
-
(2011)
J. Am. Soc. Nephrol.
, vol.22
, pp. 1335-1341
-
-
Holdaas, H.1
-
49
-
-
79959695664
-
Statins inflammation and kidney disease
-
Krane, V. & Wanner, C. Statins, inflammation and kidney disease. Nat. Rev. Nephrol. 7, 385-397 (2011).
-
(2011)
Nat. Rev. Nephrol.
, vol.7
, pp. 385-397
-
-
Krane, V.1
Wanner, C.2
-
50
-
-
0032784499
-
Serum C reactive protein (CRP) and risk of death in chronic dialysis patients
-
Iseki, K., Tozawa, M., Yoshi, S. & Fukiyama, K. Serum C reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol. Dial. Transplant. 14, 1956-1960 (1999).
-
(1999)
Nephrol. Dial. Transplant.
, vol.14
, pp. 1956-1960
-
-
Iseki, K.1
Tozawa, M.2
Yoshi, S.3
Fukiyama, K.4
-
51
-
-
56549092147
-
Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis
-
Krane, V. et al. Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis. Kidney Int. 74, 1461-1467 (2008).
-
(2008)
Kidney Int.
, vol.74
, pp. 1461-1467
-
-
Krane, V.1
-
52
-
-
0033800718
-
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice
-
Laufs, U. et al. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31, 2442-2449 (2000).
-
(2000)
Stroke
, vol.31
, pp. 2442-2449
-
-
Laufs, U.1
-
53
-
-
0035936406
-
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study
-
Zoccali, C. et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358, 2113-2117 (2001).
-
(2001)
Lancet
, vol.358
, pp. 2113-2117
-
-
Zoccali, C.1
-
54
-
-
28444435118
-
Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach
-
Ravani, P. et al. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach. J. Am. Soc. Nephrol. 16, 2449-2455 (2005).
-
(2005)
J. Am. Soc. Nephrol.
, vol.16
, pp. 2449-2455
-
-
Ravani, P.1
-
55
-
-
4944262612
-
Survival after coronary revascularization among patients with kidney disease
-
Hemmelgarn, B. R. et al. Survival after coronary revascularization among patients with kidney disease. Circulation 110, 1890-1895 (2004).
-
(2004)
Circulation
, vol.110
, pp. 1890-1895
-
-
Hemmelgarn, B.R.1
-
56
-
-
0034951268
-
Differential survival after coronary revascularization procedures among patients with renal insufficiency
-
Szczech, L. A. et al. Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int. 60, 292-299 (2001).
-
(2001)
Kidney Int.
, vol.60
, pp. 292-299
-
-
Szczech, L.A.1
-
57
-
-
0037159275
-
Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes
-
Herzog, C. A., Ma, J. Z. & Collins, A. J. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106, 2207-2211 (2002).
-
(2002)
Circulation
, vol.106
, pp. 2207-2211
-
-
Herzog, C.A.1
Ma, J.Z.2
Collins, A.J.3
-
58
-
-
2942677259
-
Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures
-
Herzog, C. A., Ma, J. Z. & Collins, A. J. Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures. Circulation 109, 2866-2871 (2004).
-
(2004)
Circulation
, vol.109
, pp. 2866-2871
-
-
Herzog, C.A.1
Ma, J.Z.2
Collins, A.J.3
-
59
-
-
34548435117
-
Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation
-
Hage, F. G. et al. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am. J. Cardiol. 100, 1020-1025 (2007).
-
(2007)
Am. J. Cardiol.
, vol.100
, pp. 1020-1025
-
-
Hage, F.G.1
-
60
-
-
77952305530
-
Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis
-
Sunagawa, G. et al. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Ann. Thorac. Surg. 89, 1896-1900 (2010).
-
(2010)
Ann. Thorac. Surg.
, vol.89
, pp. 1896-1900
-
-
Sunagawa, G.1
-
61
-
-
67651162307
-
Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: Does a drug-eluting stent have an impact on clinical outcome?
-
Manabe, S. et al. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: Does a drug-eluting stent have an impact on clinical outcome? J. Card. Surg. 24, 234-239 (2009).
-
(2009)
J Card. Surg.
, vol.24
, pp. 234-239
-
-
Manabe, S.1
-
62
-
-
28844443938
-
Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS IV trial
-
Halkin, A. et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS IV trial. Am. Heart J. 150, 1163-1170 (2005).
-
(2005)
Am. Heart J.
, vol.150
, pp. 1163-1170
-
-
Halkin, A.1
-
63
-
-
0036135463
-
Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure
-
Gruberg, L. et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter. Cardiovasc. Interv. 55, 66-72 (2002).
-
(2002)
Catheter. Cardiovasc. Interv.
, vol.55
, pp. 66-72
-
-
Gruberg, L.1
-
64
-
-
79953693894
-
Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3 year clinical outcomes after sirolimus-eluting stent implantation: Insights from the Japan multi-centre post-marketing surveillance registry
-
Otsuka, Y. et al. Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3 year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-centre post-marketing surveillance registry. Eur. Heart J. 32, 829-837 (2011).
-
(2011)
Eur. Heart J.
, vol.32
, pp. 829-837
-
-
Otsuka, Y.1
-
65
-
-
0141765805
-
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
-
Moses, J. W. et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med. 349, 1315-1323 (2003).
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 1315-1323
-
-
Moses, J.W.1
-
66
-
-
9144249927
-
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
-
Stone, G. W. et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N. Engl. J. Med. 350, 221-231 (2004).
-
(2004)
N. Engl. J. Med.
, vol.350
, pp. 221-231
-
-
Stone, G.W.1
-
67
-
-
33644596656
-
Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents
-
Kuchulakanti, P. K. et al. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am. J. Cardiol. 97, 792-797 (2006).
-
(2006)
Am. J. Cardiol.
, vol.97
, pp. 792-797
-
-
Kuchulakanti, P.K.1
-
68
-
-
80054998092
-
Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: A report from the linked CathPCI Registry- CMS Claims Database
-
Tsai, T. T. et al. Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: A report from the linked CathPCI Registry- CMS Claims Database. J. Am. Coll. Cardiol. 58, 1859-1869 (2011).
-
(2011)
J. Am. Coll. Cardiol.
, vol.58
, pp. 1859-1869
-
-
Tsai, T.T.1
-
69
-
-
33748750070
-
Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization
-
Das, P. et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J. Invasive Cardiol. 18, 405-408 (2006).
-
(2006)
J. Invasive Cardiol.
, vol.18
, pp. 405-408
-
-
Das, P.1
-
70
-
-
80955158525
-
Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry)
-
Green, S. M. et al. Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry). Am. J. Cardiol. 108, 1658-1664 (2011).
-
(2011)
Am. J. Cardiol.
, vol.108
, pp. 1658-1664
-
-
Green, S.M.1
-
71
-
-
33846132591
-
Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients
-
Halkin, A. et al. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J. Invasive Cardiol. 18, 577-583 (2006).
-
(2006)
J. Invasive Cardiol.
, vol.18
, pp. 577-583
-
-
Halkin, A.1
-
72
-
-
68349109552
-
Diminished benefits of drug-eluting stents versus bare metal stents in patients with severe renal insufficiency
-
Rosenblum, M. A., Robbins, M. J., Farkouh, M. E., Winston, J. A. & Kim, M. C. Diminished benefits of drug-eluting stents versus bare metal stents in patients with severe renal insufficiency. Nephron Clin. Pract. 113, c198- c202 (2009).
-
(2009)
Nephron Clin. Pract.
, vol.113
-
-
Rosenblum, M.A.1
Robbins, M.J.2
Farkouh, M.E.3
Winston, J.A.4
Kim, M.C.5
-
73
-
-
76749142034
-
Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency
-
Syed, A. I. et al. Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency. J. Interv. Cardiol. 23, 33-39 (2010).
-
(2010)
J. Interv. Cardiol.
, vol.23
, pp. 33-39
-
-
Syed, A.I.1
-
74
-
-
34948830243
-
Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients
-
Ishio, I. et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ. J. 71, 1525-1529 (2007).
-
(2007)
Circ. J.
, vol.71
, pp. 1525-1529
-
-
Ishio, I.1
-
75
-
-
67650432182
-
Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients
-
Yachi, S. et al. Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. Am. J. Kidney Dis. 54, 299-306 (2009).
-
(2009)
Am. J. Kidney Dis.
, vol.54
, pp. 299-306
-
-
Yachi, S.1
-
76
-
-
39849084996
-
Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis
-
Aoyama, T. et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ. J. 72, 56-60 (2008).
-
(2008)
Circ. J.
, vol.72
, pp. 56-60
-
-
Aoyama, T.1
-
77
-
-
84862882941
-
Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years
-
Simsek, C. et al. Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years. Catheter. Cardiovasc. Interv. 80, 18-26 (2012).
-
(2012)
Catheter. Cardiovasc. Interv.
, vol.80
, pp. 18-26
-
-
Simsek, C.1
-
78
-
-
54449098488
-
Cardiorenal syndrome
-
Ronco, C., Haapio, M., House, A. A., Anavekar, N. & Bellomo, R. Cardiorenal syndrome. J. Am. Coll. Cardiol. 52, 1527-1539 (2008).
-
(2008)
J. Am. Coll. Cardiol.
, vol.52
, pp. 1527-1539
-
-
Ronco, C.1
Haapio, M.2
House, A.A.3
Anavekar, N.4
Bellomo, R.5
-
79
-
-
80052296951
-
Cardiovascular disease in chronic kidney disease: A clinical update from kidney disease: Improving global outcomes (kdigo)
-
Herzog. et al. Cardiovascular disease in chronic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 80, 572-586 (2011).
-
(2011)
Kidney Int.
, vol.80
, pp. 572-586
-
-
Herzog1
-
80
-
-
0034751209
-
A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients
-
Stack, A. G. & Bloembergen, W. E. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am. J. Kidney Dis. 38, 992-1000 (2001).
-
(2001)
Am. J. Kidney Dis.
, vol.38
, pp. 992-1000
-
-
Stack, A.G.1
Bloembergen, W.E.2
-
81
-
-
0028939185
-
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
-
Foley, R. N. et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 47, 186-192 (1995).
-
(1995)
Kidney Int.
, vol.47
, pp. 186-192
-
-
Foley, R.N.1
-
82
-
-
0031727746
-
Long-term evolution of cardiomyopathy in dialysis patients
-
Foley, R. N. et al. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int. 54, 1720-1725 (1998).
-
(1998)
Kidney Int.
, vol.54
, pp. 1720-1725
-
-
Foley, R.N.1
-
83
-
-
77953776647
-
Cardiorenal syndrome: New perspectives
-
Bock, J. S. & Gottlieb, S. S. Cardiorenal syndrome: new perspectives. Circulation 121, 2592-2600 (2010).
-
(2010)
Circulation
, vol.121
, pp. 2592-2600
-
-
Bock, J.S.1
Gottlieb, S.S.2
-
84
-
-
26044460566
-
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial
-
Binanay, C. et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA 294, 1625-1633 (2005).
-
(2005)
JAMA
, vol.294
, pp. 1625-1633
-
-
Binanay, C.1
-
85
-
-
38149128221
-
Elevated intra-abdominal pressure in acute decompensated heart failure: A potential contributor to worsening renal function?
-
Mullens, W. et al. Elevated intra-abdominal pressure in acute decompensated heart failure: A potential contributor to worsening renal function? J. Am. Coll. Cardiol. 51, 300-306 (2008).
-
(2008)
J Am. Coll. Cardiol.
, vol.51
, pp. 300-306
-
-
Mullens, W.1
-
86
-
-
59649118099
-
Importance of venous congestion for worsening of renal function in advanced decompensated heart failure
-
Mullens, W. et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J. Am. Coll. Cardiol. 53, 589-596 (2009).
-
(2009)
J. Am. Coll. Cardiol.
, vol.53
, pp. 589-596
-
-
Mullens, W.1
-
87
-
-
59649087169
-
Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease
-
Damman, K. et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J. Am. Coll. Cardiol. 53, 582-588 (2009).
-
(2009)
J. Am. Coll. Cardiol.
, vol.53
, pp. 582-588
-
-
Damman, K.1
-
88
-
-
0033514046
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomised trial
-
CIBIS-II Investigators and Committees.
-
CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomised trial. Lancet 353, 9-13 (1999).
-
(1999)
Lancet
, vol.353
, pp. 9-13
-
-
-
89
-
-
77953001086
-
Improved survival with bisoprolol in patients with heart failure and renal impairment: An analysis of the cardiac insufficiency bisoprolol study II (CIBIS II) trial
-
Castagno, D. et al. Improved survival with bisoprolol in patients with heart failure and renal impairment: An analysis of the cardiac insufficiency bisoprolol study II (CIBIS II) trial. Eur. J. Heart Fail. 12, 607-616 (2010).
-
(2010)
Eur. J. Heart Fail.
, vol.12
, pp. 607-616
-
-
Castagno, D.1
-
90
-
-
65349180809
-
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: Insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT HF)
-
Ghali, J. K. et al. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT HF). J. Card. Fail. 15, 310-318 (2009).
-
(2009)
J. Card. Fail.
, vol.15
, pp. 310-318
-
-
Ghali, J.K.1
-
91
-
-
80052365390
-
Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis
-
Badve, S. V. et al. Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis. J. Am. Coll. Cardiol. 58, 1152-1161 (2011).
-
(2011)
J. Am. Coll. Cardiol.
, vol.58
, pp. 1152-1161
-
-
Badve, S.V.1
-
92
-
-
0035131087
-
Dilated cardiomyopathy in dialysis patients-beneficial effects of carvedilol: A double-blind, placebo-controlled trial
-
Cice, G. et al. Dilated cardiomyopathy in dialysis patients - beneficial effects of carvedilol: A double-blind, placebo-controlled trial. J. Am. Coll. Cardiol. 37, 407-411 (2001).
-
(2001)
J. Am. Coll. Cardiol.
, vol.37
, pp. 407-411
-
-
Cice, G.1
-
93
-
-
0038408916
-
Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial
-
Cice, G. et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial. J. Am. Coll. Cardiol. 41, 1438-1444 (2003).
-
(2003)
J. Am. Coll. Cardiol.
, vol.41
, pp. 1438-1444
-
-
Cice, G.1
-
94
-
-
0034642827
-
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: Is this a cause for concern?
-
Bakris, G. L. & Weir, M. R. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch. Intern. Med. 160, 685-693 (2000).
-
(2000)
Arch Intern. Med.
, vol.160
, pp. 685-693
-
-
Bakris, G.L.1
Weir, M.R.2
-
95
-
-
33748949733
-
Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies
-
Zannad, F. et al. Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies. Kidney Int. 70, 1318-1324 (2006).
-
(2006)
Kidney Int.
, vol.70
, pp. 1318-1324
-
-
Zannad, F.1
-
96
-
-
49749083154
-
Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: An open-label randomized controlled trial
-
Suzuki, H. et al. Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: An open-label randomized controlled trial. Am. J. Kidney Dis. 52, 501-506 (2008).
-
(2008)
Am. J. Kidney Dis.
, vol.52
, pp. 501-506
-
-
Suzuki, H.1
-
97
-
-
0035818884
-
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
-
Cohn, J. N. et al. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med. 45, 1667-1675 (2001).
-
(2001)
N. Engl. J. Med.
, vol.45
, pp. 1667-1675
-
-
Cohn, J.N.1
-
98
-
-
0023266532
-
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
-
CONSENSUS Trial Study Group
-
CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N. Engl. J. Med. 31, 1429-1435 (1987).
-
(1987)
N. Engl. J. Med.
, vol.31
, pp. 1429-1435
-
-
-
99
-
-
0026786643
-
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction-results of the Survival And Ventricular Enlargement trial
-
Pfeffer, M. A. et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction - results of the Survival And Ventricular Enlargement trial. N. Engl. J. Med. 327, 669-677 (1992).
-
(1992)
N. Engl. J. Med.
, vol.327
, pp. 669-677
-
-
Pfeffer, M.A.1
-
100
-
-
0026785561
-
-
SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
-
SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N. Engl. J. Med. 327, 685-691 (1992).
-
(1992)
N. Engl. J. Med.
, vol.327
, pp. 685-691
-
-
-
101
-
-
0027423378
-
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
-
Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
-
Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342, 821-828 (1993).
-
(1993)
Lancet
, vol.342
, pp. 821-828
-
-
-
102
-
-
0035818884
-
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
-
Cohn, J. N. et al. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med. 345, 1667-1675 (2001).
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 1667-1675
-
-
Cohn, J.N.1
-
103
-
-
0042410539
-
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme
-
Pfeffer, M. A. et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme. Lancet 362, 759-766 (2003).
-
(2003)
Lancet
, vol.362
, pp. 759-766
-
-
Pfeffer, M.A.1
-
104
-
-
70350228940
-
Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure
-
Anand, I. S. et al. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Circulation 120, 1577-1584 (2009).
-
(2009)
Circulation
, vol.120
, pp. 1577-1584
-
-
Anand, I.S.1
-
105
-
-
78349252300
-
Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure: A double-blind, placebo-controlled trial
-
Cice, G. et al. Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure: A double-blind, placebo-controlled trial. J. Am. Coll. Cardiol. 56, 1701-1708 (2010).
-
(2010)
J. Am. Coll. Cardiol.
, vol.56
, pp. 1701-1708
-
-
Cice, G.1
-
106
-
-
0033517302
-
The effect of spironolactone on morbidity and mortality in patients with severe heart failure
-
Pitt, B. et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341, 709-717 (1999).
-
(1999)
N. Engl. J. Med.
, vol.341
, pp. 709-717
-
-
Pitt, B.1
-
107
-
-
0037417252
-
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
-
Pitt, B. et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309-1321 (2003).
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 1309-1321
-
-
Pitt, B.1
-
108
-
-
32844467281
-
Beneficial impact of spironolactone in diabetic nephropathy
-
Schjoedt, K. J. et al. Beneficial impact of spironolactone in diabetic nephropathy. Kidney Int. 68, 2829-2836 (2005).
-
(2005)
Kidney Int.
, vol.68
, pp. 2829-2836
-
-
Schjoedt, K.J.1
-
109
-
-
33845302661
-
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
-
Bianchi, S., Bigazzi, R. & Campese, V. M. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int. 70, 2116-2123 (2006).
-
(2006)
Kidney Int.
, vol.70
, pp. 2116-2123
-
-
Bianchi, S.1
Bigazzi, R.2
Campese, V.M.3
-
110
-
-
33746558934
-
Double-blind placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker
-
Chrysostomou, A., Pedagogos, E., MacGregor, L. & Becker, G. J. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker. Clin. J. Am. Soc. Nephrol. 1, 256-262 (2006).
-
(2006)
Clin. J. Am. Soc. Nephrol.
, vol.1
, pp. 256-262
-
-
Chrysostomou, A.1
Pedagogos, E.2
MacGregor, L.3
Becker, G.J.4
-
111
-
-
38149030811
-
Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: A systematic review
-
Bomback, A. S., Kshirsagar, A. V., Amamoo, M. A. & Klemmer, P. J. Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: A systematic review. Am. J. Kidney Dis. 51, 199-211 (2008).
-
(2008)
Am. J. Kidney Dis.
, vol.51
, pp. 199-211
-
-
Bomback, A.S.1
Kshirsagar, A.V.2
Amamoo, M.A.3
Klemmer, P.J.4
-
112
-
-
66149131479
-
Aldosterone antagonists for preventing the progression of chronic kidney disease: A systematic review and meta-analysis
-
Navaneethan, S. D., Nigwekar, S. U., Sehgal, A. R. & Strippoli, G. F. Aldosterone antagonists for preventing the progression of chronic kidney disease: A systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 4, 542-551 (2009).
-
(2009)
Clin. J. Am. Soc. Nephrol.
, vol.4
, pp. 542-551
-
-
Navaneethan, S.D.1
Nigwekar, S.U.2
Sehgal, A.R.3
Strippoli, G.F.4
-
113
-
-
78149424364
-
Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease
-
Edwards, N. C. et al. Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease. Am. J. Cardiol. 106, 1505-1511 (2010).
-
(2010)
Am. J. Cardiol.
, vol.106
, pp. 1505-1511
-
-
Edwards, N.C.1
-
114
-
-
0242320293
-
Safety of low-dose spironolactone administration in chronic haemodialysis patients
-
Saudan, P. et al. Safety of low-dose spironolactone administration in chronic haemodialysis patients. Nephrol. Dial. Transplant. 18, 2359-2363 (2003).
-
(2003)
Nephrol. Dial. Transplant.
, vol.18
, pp. 2359-2363
-
-
Saudan, P.1
-
115
-
-
0242288593
-
Is spironolactone safe for dialysis patients? Nephrol
-
Hussain, S., Dreyfus, D. E., Marcus, R. J., Biederman, R. W. & McGill, R. L. Is spironolactone safe for dialysis patients? Nephrol. Dial. Transplant. 18, 2364-2368 (2003).
-
(2003)
Dial. Transplant.
, vol.18
, pp. 2364-2368
-
-
Hussain, S.1
Dreyfus, D.E.2
Marcus, R.J.3
Biederman, R.W.4
McGill, R.L.5
-
116
-
-
4644313400
-
Effect of spironolactone on K+ homeostasis and ENaC expression in lymphocytes from chronic hemodialysis patients
-
Michea, L., Vukusich, A., González, M., Zehnder, C. & Marusic, E. T. Effect of spironolactone on K+ homeostasis and ENaC expression in lymphocytes from chronic hemodialysis patients. Kidney Int. 66, 1647-1653 (2004).
-
(2004)
Kidney Int.
, vol.66
, pp. 1647-1653
-
-
Michea, L.1
Vukusich, A.2
González, M.3
Zehnder, C.4
Marusic, E.T.5
-
117
-
-
63349097399
-
Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients
-
Matsumoto, Y. et al. Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients. Cardiology 114, 32-38 (2009).
-
(2009)
Cardiology
, vol.114
, pp. 32-38
-
-
Matsumoto, Y.1
-
119
-
-
77956514750
-
Digoxin associates with mortality in ESRD
-
Chan, K. E., Lazarus, J. M. & Hakim, R. M. Digoxin associates with mortality in ESRD. J. Am. Soc. Nephrol. 21, 1550-1559 (2010).
-
(2010)
J. Am. Soc. Nephrol.
, vol.21
, pp. 1550-1559
-
-
Chan, K.E.1
Lazarus, J.M.2
Hakim, R.M.3
-
120
-
-
33845475422
-
A method of determining the dose of digoxin for heart failure in the modern era
-
Bauman, J. L., DiDomenico, R. J., Viana, M. & Fitch, M. A method of determining the dose of digoxin for heart failure in the modern era. Arch. Intern. Med. 166, 2539-2545 (2006).
-
(2006)
Arch. Intern. Med.
, vol.166
, pp. 2539-2545
-
-
Bauman, J.L.1
DiDomenico, R.J.2
Viana, M.3
Fitch, M.4
-
121
-
-
33744510817
-
Relation of loop diuretic dose to mortality in advanced heart failure
-
Eshaghian, S., Horwich, T. B. & Fonarow, G. C. Relation of loop diuretic dose to mortality in advanced heart failure. Am. J. Cardiol. 97, 1759-1764 (2006).
-
(2006)
Am. J. Cardiol.
, vol.97
, pp. 1759-1764
-
-
Eshaghian, S.1
Horwich, T.B.2
Fonarow, G.C.3
-
122
-
-
0033534085
-
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
-
Packer, M. et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 100, 2312-2318 (1999).
-
(1999)
Circulation
, vol.100
, pp. 2312-2318
-
-
Packer, M.1
-
123
-
-
0023231642
-
Aortic and mitral valve calcification in patients with end-stage renal disease
-
Maher, E. R., Young, G., Smyth-Walsh, B., Pugh, S. & Curtis, J. R. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 2, 875-877 (1987).
-
(1987)
Lancet
, vol.2
, pp. 875-877
-
-
Maher, E.R.1
Young, G.2
Smyth-Walsh, B.3
Pugh, S.4
Curtis, J.R.5
-
124
-
-
0026550712
-
Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis
-
Straumann, E. et al. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br. Heart J. 62, 236-239 (1992).
-
(1992)
Br. Heart J.
, vol.62
, pp. 236-239
-
-
Straumann, E.1
-
125
-
-
0347906220
-
Accelerated progression of calcific aortic stenosis in dialysis patients
-
Perkovic, V. et al. Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin. Pract. 94, c40- c45 (2003).
-
(2003)
Nephron Clin. Pract.
, vol.94
-
-
Perkovic, V.1
-
126
-
-
0023232653
-
Calcific aortic stenosis: A complication of chronic uraemia
-
Maher, E. R., Pazianas, M. & Curtis, J. R. Calcific aortic stenosis: A complication of chronic uraemia. Nephron 47, 119-122 (1987).
-
(1987)
Nephron
, vol.47
, pp. 119-122
-
-
Maher, E.R.1
Pazianas, M.2
Curtis, J.R.3
-
127
-
-
33745670164
-
Rate of progression of valvular aortic stenosis in patients undergoing dialysis
-
Kume, T. et al. Rate of progression of valvular aortic stenosis in patients undergoing dialysis. J. Am. Soc. Echocardiogr. 19, 914-918 (2006).
-
(2006)
J. Am. Soc. Echocardiogr.
, vol.19
, pp. 914-918
-
-
Kume, T.1
-
128
-
-
0037133592
-
Long-term survival of dialysis patients in the United States with prosthetic heart valves: Should ACC/AHA practice guidelines on valve selection be modified?
-
Herzog, C A., Ma J. Z. & Collins, A. J. Long-term survival of dialysis patients in the United States with prosthetic heart valves: Should ACC/AHA practice guidelines on valve selection be modified? Circulation 105, 1336-1341 (2002).
-
(2002)
Circulation
, vol.105
, pp. 1336-1341
-
-
Herzog, C.A.1
Ma, J.Z.2
Collins, A.J.3
-
129
-
-
55249125191
-
2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease
-
a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
-
Bonow, R. O. et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118, e523- e661 (2008).
-
(2008)
Circulation
, vol.118
-
-
Bonow, R.O.1
-
130
-
-
0033836213
-
Cardiac valve replacement in patients on dialysis: Influence of prosthesis on survival
-
Kaplon, R. J. et al. Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann. Thorac. Surg. 70, 438-441 (2000).
-
(2000)
Ann. Thorac. Surg.
, vol.70
, pp. 438-441
-
-
Kaplon, R.J.1
-
131
-
-
0036308859
-
Valve replacement in patients on chronic renal dialysis: Implications for valve prosthesis selection
-
Brinkman, W. T., Williams, W. H., Guyton, R. A., Jones, E. L. & Craver, J. M. Valve replacement in patients on chronic renal dialysis: implications for valve prosthesis selection. Ann. Thorac. Surg. 74, 37-42 (2002).
-
(2002)
Ann. Thorac. Surg.
, vol.74
, pp. 37-42
-
-
Brinkman, W.T.1
Williams, W.H.2
Guyton, R.A.3
Jones, E.L.4
Craver, J.M.5
-
132
-
-
32644472467
-
Valve replacement surgery in end-stage renal failure: Mechanical prostheses versus bioprostheses
-
Chan, V. et al. Valve replacement surgery in end-stage renal failure: mechanical prostheses versus bioprostheses. Ann. Thorac. Surg. 81, 857-862 (2006).
-
(2006)
Ann. Thorac. Surg.
, vol.81
, pp. 857-862
-
-
Chan, V.1
-
133
-
-
82255192469
-
Heart valve prosthesis selection in patients with end-stage renal disease requiring dialysis: A systematic review and meta-analysis
-
Chan, V., Chen, L., Mesana, L., Mesana, T. G. & Ruel, M. Heart valve prosthesis selection in patients with end-stage renal disease requiring dialysis: A systematic review and meta-analysis. Heart 97, 2033-2037 (2011).
-
(2011)
Heart
, vol.97
, pp. 2033-2037
-
-
Chan, V.1
Chen, L.2
Mesana, L.3
Mesana, T.G.4
Ruel, M.5
-
134
-
-
65249183151
-
Dilemmas in the management of atrial fibrillation in chronic kidney disease
-
Reinecke, H. et al. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J. Am. Soc. Nephrol. 20, 705-711 (2009).
-
(2009)
J. Am. Soc. Nephrol.
, vol.20
, pp. 705-711
-
-
Reinecke, H.1
-
135
-
-
80655139710
-
Warfarin in atrial fibrillation patients with moderate chronic kidney disease
-
Hart, R. G., Pearce, L. A., Asinger, R. W. & Herzog, C. A. Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 2599-2604 (2011).
-
(2011)
Clin. J. Am. Soc. Nephrol.
, vol.6
, pp. 2599-2604
-
-
Hart, R.G.1
Pearce, L.A.2
Asinger, R.W.3
Herzog, C.A.4
-
136
-
-
79952316518
-
Chronic kidney disease and CHADS2 score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation
-
Nakagawa, K. et al. Chronic kidney disease and CHADS2 score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation. Am. J. Cardiol. 107, 912-916 (2011).
-
(2011)
Am. J. Cardiol.
, vol.107
, pp. 912-916
-
-
Nakagawa, K.1
-
137
-
-
84867022051
-
Anticoagulants in atrial fibrillation patients with chronic kidney disease
-
Hart, R. G., Eikelboom, J. W., Ingram, A. J. & Herzog, C. A. Anticoagulants in atrial fibrillation patients with chronic kidney disease. Nat. Rev. Nephrol. 8, 569-578 (2012).
-
(2012)
Nat. Rev. Nephrol.
, vol.8
, pp. 569-578
-
-
Hart, R.G.1
Eikelboom, J.W.2
Ingram, A.J.3
Herzog, C.A.4
-
138
-
-
0141794137
-
Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis
-
Vázquez, E. et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am. J. Cardiol. 92, 868-871 (2003).
-
(2003)
Am. J. Cardiol.
, vol.92
, pp. 868-871
-
-
Vázquez, E.1
-
139
-
-
67651124821
-
Atrial fibrillation in incident dialysis patients
-
Vázquez, E. et al. Atrial fibrillation in incident dialysis patients. Kidney Int. 76, 324-330 (2009).
-
(2009)
Kidney Int.
, vol.76
, pp. 324-330
-
-
Vázquez, E.1
-
140
-
-
65249178935
-
Kidney function influences warfarin responsiveness and hemorrhagic complications
-
Limdi, N. A. et al. Kidney function influences warfarin responsiveness and hemorrhagic complications. J. Am. Soc. Nephrol. 20, 912-921 (2009).
-
(2009)
J. Am. Soc. Nephrol.
, vol.20
, pp. 912-921
-
-
Limdi, N.A.1
-
141
-
-
78649336758
-
Warfarin in haemodialysis patients with atrial fibrillation: What benefit?
-
Yang, F., Chou, D., Schweitzer, P & Hanon, S. Warfarin in haemodialysis patients with atrial fibrillation: what benefit? Europace 12, 1666-1672 (2010).
-
(2010)
Europace
, vol.12
, pp. 1666-1672
-
-
Yang, F.1
Chou, D.2
Schweitzer, P.3
Hanon, S.4
-
142
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
Connolly, S. J. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361, 1139-1151 (2009).
-
(2009)
N. Engl. J. Med.
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
-
143
-
-
79952301326
-
Apixaban in patients with atrial fibrillation
-
Connolly, S. J. et al. Apixaban in patients with atrial fibrillation. N. Engl. J. Med. 364, 806-817 (2011).
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 806-817
-
-
Connolly, S.J.1
-
144
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
Granger, C. B. et al. Apixaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 365, 981-992 (2011).
-
(2011)
N. Engl. J. Med.
, vol.365
, pp. 981-992
-
-
Granger, C.B.1
-
145
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
Patel, M. R. et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med. 365, 883-891 (2011).
-
(2011)
N. Engl. J. Med.
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
-
146
-
-
79953332012
-
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: Prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter
-
Cairns, J. A. et al. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: Prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can. J. Cardiol. 27, 74-90 (2011).
-
(2011)
Can. J. Cardiol.
, vol.27
, pp. 74-90
-
-
Cairns, J.A.1
-
147
-
-
79956352144
-
Sudden cardiac death in hemodialysis patients: An in-depth review
-
Green, D. et al. Sudden cardiac death in hemodialysis patients: An in-depth review. Am. J. Kidney Dis. 57, 921-929 (2011).
-
(2011)
Am. J. Kidney Dis.
, vol.57
, pp. 921-929
-
-
Green, D.1
-
148
-
-
26944454055
-
Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators
-
Herzog, C. A. et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 68, 818-825 (2005).
-
(2005)
Kidney Int.
, vol.68
, pp. 818-825
-
-
Herzog, C.A.1
-
149
-
-
44749094014
-
Outcome of patients on renal replacement therapy after colorectal surgery
-
Krysa, J. et al. Outcome of patients on renal replacement therapy after colorectal surgery. Dis. Colon Rectum 51, 961-965 (2008).
-
(2008)
Dis. Colon Rectum
, vol.51
, pp. 961-965
-
-
Krysa, J.1
-
150
-
-
0034642322
-
Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery
-
Liu, J. Y. et al. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Circulation 102, 2973-2977 (2000).
-
(2000)
Circulation
, vol.102
, pp. 2973-2977
-
-
Liu, J.Y.1
-
151
-
-
34447570985
-
Risks of coronary artery bypass surgery in dialysis-dependent patients-analysis of the 2001 National Inpatient Sample
-
Charytan, D. M. & Kuntz, R. E. Risks of coronary artery bypass surgery in dialysis-dependent patients - analysis of the 2001 National Inpatient Sample. Nephrol. Dial. Transplant. 22, 1665-1671 (2007).
-
(2007)
Nephrol. Dial. Transplant.
, vol.22
, pp. 1665-1671
-
-
Charytan, D.M.1
Kuntz, R.E.2
-
152
-
-
0032041939
-
Prognostic value of dipyridamole thallium 201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation
-
Mistry, B. M. et al. Prognostic value of dipyridamole thallium 201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Clin. Transplant. 12, 130-135 (1998).
-
(1998)
Clin. Transplant.
, vol.12
, pp. 130-135
-
-
Mistry, B.M.1
-
153
-
-
0029157691
-
The evaluation of renal transplant candidates: Clinical practice guidelines Patient care and education committee of the american society of transplant physicians
-
Kasiske, B. L. et al. The evaluation of renal transplant candidates: Clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J. Am. Soc. Nephrol. 6, 1-34 (1995).
-
(1995)
J. Am. Soc. Nephrol.
, vol.6
, pp. 1-34
-
-
Kasiske, B.L.1
-
154
-
-
37449014922
-
ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery
-
a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery
-
Fleisher, L. A. et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 116, e418- e499 (2007).
-
(2007)
Circulation
, vol.116
-
-
Fleisher, L.A.1
-
155
-
-
20144387624
-
Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease
-
Wali, R. K. et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J. Am. Coll. Cardiol. 45, 1051-1060 (2005).
-
(2005)
J. Am. Coll. Cardiol.
, vol.45
, pp. 1051-1060
-
-
Wali, R.K.1
|